newsfilter
← Latest News
GlobeNewswire·

Sigyn Therapeutics™ Discloses PCT Patent Submission to Enhance Chemotherapy Delivery and Reduce Cancer Treatment Toxicity

SAN DIEGO, CA, Oct. 04, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sigyn Therapeutics, Inc. ("Sigyn" or the "Company") (OTCQB:SIGY), a development-stage medical technology company, today disclosed the submission of a